154 related articles for article (PubMed ID: 15998737)
1. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers.
Ippolito JE; Xu J; Jain S; Moulder K; Mennerick S; Crowley JR; Townsend RR; Gordon JI
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9901-6. PubMed ID: 15998737
[TBL] [Abstract][Full Text] [Related]
2. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers.
Ippolito JE; Merritt ME; Bäckhed F; Moulder KL; Mennerick S; Manchester JK; Gammon ST; Piwnica-Worms D; Gordon JI
Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12505-10. PubMed ID: 16895983
[TBL] [Abstract][Full Text] [Related]
3. Current concepts in neuroendocrine cancer metabolism.
Ippolito JE
Pituitary; 2006; 9(3):193-202. PubMed ID: 17001465
[TBL] [Abstract][Full Text] [Related]
4. RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.
Hu Y; Wang T; Stormo GD; Gordon JI
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5559-64. PubMed ID: 15060276
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice.
Hu Y; Ippolito JE; Garabedian EM; Humphrey PA; Gordon JI
J Biol Chem; 2002 Nov; 277(46):44462-74. PubMed ID: 12228243
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
7. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
Sadanandam A; Wullschleger S; Lyssiotis CA; Grötzinger C; Barbi S; Bersani S; Körner J; Wafy I; Mafficini A; Lawlor RT; Simbolo M; Asara JM; Bläker H; Cantley LC; Wiedenmann B; Scarpa A; Hanahan D
Cancer Discov; 2015 Dec; 5(12):1296-313. PubMed ID: 26446169
[TBL] [Abstract][Full Text] [Related]
8. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
9. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype.
Syder AJ; Karam SM; Mills JC; Ippolito JE; Ansari HR; Farook V; Gordon JI
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4471-6. PubMed ID: 15070742
[TBL] [Abstract][Full Text] [Related]
10. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
Yuan TC; Veeramani S; Lin MF
Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
[TBL] [Abstract][Full Text] [Related]
12. Detection of neuroendocrine tumors using promoter-specific secreted Gaussia luciferase.
Tseng AW; Akerstrom V; Chen C; Breslin MB; Lan MS
Int J Oncol; 2016 Jan; 48(1):173-80. PubMed ID: 26530405
[TBL] [Abstract][Full Text] [Related]
13. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
[TBL] [Abstract][Full Text] [Related]
14. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
15. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
16. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP
Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641
[TBL] [Abstract][Full Text] [Related]
17. Characterization of prostatic neuroendocrine cell line established from neuroendocrine carcinoma of transgenic mouse allograft model.
Uchida K; Masumori N; Takahashi A; Itoh N; Tsukamoto T
Prostate; 2005 Jan; 62(1):40-8. PubMed ID: 15389815
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.
Hashimoto K; Masumori N; Tanaka T; Maeda T; Kobayashi K; Kitamura H; Hirata K; Tsukamoto T
Prostate; 2013 Apr; 73(5):500-11. PubMed ID: 22996996
[TBL] [Abstract][Full Text] [Related]
20. Efficient human interferon-alpha gene transfer to neuroendocrine tumor cells with long-term and stable expression.
Liu M; Kilarski WW; Gerwins P; Oberg K; Zhou Y
Neuroendocrinology; 2005; 82(5-6):264-73. PubMed ID: 16721032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]